IBDEI0MP ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10202,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,10202,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,10202,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,10203,0)
 ;;=E11.610^^39^431^9
 ;;^UTILITY(U,$J,358.3,10203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10203,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,10203,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,10203,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,10204,0)
 ;;=E11.618^^39^431^26
 ;;^UTILITY(U,$J,358.3,10204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10204,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,10204,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,10204,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,10205,0)
 ;;=E11.621^^39^431^16
 ;;^UTILITY(U,$J,358.3,10205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10205,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,10205,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,10205,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,10206,0)
 ;;=E11.622^^39^431^31
 ;;^UTILITY(U,$J,358.3,10206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10206,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,10206,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,10206,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,10207,0)
 ;;=E11.628^^39^431^30
 ;;^UTILITY(U,$J,358.3,10207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10207,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,10207,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,10207,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,10208,0)
 ;;=E11.630^^39^431^33
 ;;^UTILITY(U,$J,358.3,10208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10208,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,10208,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,10208,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,10209,0)
 ;;=E11.638^^39^431^29
 ;;^UTILITY(U,$J,358.3,10209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10209,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,10209,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,10209,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,10210,0)
 ;;=E11.641^^39^431^20
 ;;^UTILITY(U,$J,358.3,10210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10210,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,10210,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,10210,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,10211,0)
 ;;=E11.649^^39^431^21
 ;;^UTILITY(U,$J,358.3,10211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10211,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,10211,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,10211,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,10212,0)
 ;;=E11.65^^39^431^17
 ;;^UTILITY(U,$J,358.3,10212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10212,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,10212,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,10212,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,10213,0)
 ;;=E11.69^^39^431^32
 ;;^UTILITY(U,$J,358.3,10213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10213,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,10213,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,10213,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,10214,0)
 ;;=E11.8^^39^431^34
 ;;^UTILITY(U,$J,358.3,10214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10214,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,10214,1,4,0)
 ;;=4^E11.8
